| Duodopa (levodopa/carbidopa intraduodenal gel infusion) / AbbVie |
NCT01956032: Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources |
|
|
| Completed | N/A | 15 | Europe | | AbbVie | Parkinson's Disease | 11/14 | 11/14 | | |
MONOTREAT, NCT01747655: A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study |
|
|
| Completed | N/A | 64 | Europe | | AbbVie (prior sponsor, Abbott) | Parkinson's Disease | 07/15 | 07/15 | | |
ADEQUA, NCT02289729: Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease |
|
|
| Completed | N/A | 62 | NA | | AbbVie | Parkinson's Disease | 11/16 | 11/16 | | |
NCT02274324: Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease |
|
|
| Unknown status | N/A | 20 | NA | different diets | Sheba Medical Center, Tel Aviv University | Parkinson Disease | 10/17 | 12/17 | | |
NCT03602924: Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion |
|
|
| Unknown status | N/A | 40 | Europe | | Hospital Universitari Vall d'Hebron Research Institute | Parkinson Disease | 07/18 | 12/18 | | |
COSMOS, NCT03362879: COmedication Study Assessing Mono- and cOmbination Therapy With Levodopa-carbidopa inteStinal Gel |
|
|
| Completed | N/A | 412 | Europe, Canada, RoW | | AbbVie | Parkinson's Disease (PD) | 12/18 | 12/18 | | |
BALANCE, NCT02381444: Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy |
|
|
| Completed | N/A | 136 | Europe | | AbbVie | Parkinson's Disease (PD) | 01/20 | 01/20 | | |
NCT02485600: Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients |
|
|
| Completed | N/A | 88 | Canada | | AbbVie | Parkinson Disease (PD) | 02/20 | 02/20 | | |
PSYCHO-PERF, NCT03793491: Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease |
|
|
| Unknown status | N/A | 60 | Europe | TCI scale, Temperament and Character Inventory scale (TCI), Quality of life scale, PDQ-39 scale, Parkinson's Disease Questionnaire (PDQ-39) | University Hospital, Toulouse | Parkinson Disease | 12/20 | 06/21 | | |
DUOGLOBE, NCT02611713: Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease |
|
|
| Completed | N/A | 213 | Europe, US, RoW | | AbbVie | Advanced Parkinson's Disease | 12/20 | 12/20 | | |
FACILITATECARE, NCT04500106: Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Participants With Parkinson's Disease Treated With Levodopa-Carbidopa Intestinal Gel |
|
|
| Completed | N/A | 41 | Europe, RoW | | AbbVie | Parkinson's Disease | 10/21 | 10/21 | | |
TeSLa-PD, NCT05072015: Systematic Follow up of Second Line Treatments for Parkinson's Disease (Deep Brain Stimulation, Apomorphin Pump, Duodopa Pump) |
|
|
| Not yet recruiting | N/A | 150 | Europe | | University Hospital, Strasbourg, France | Parkinson's Disease | 02/22 | 03/28 | | |
NCT04196647: Guideline for Hometitration With Duodopa for Parkinson Patients |
|
|
| Completed | N/A | 10 | Europe | Home titration | Rigshospitalet, Denmark, AbbVie | Parkinson Disease | 06/22 | 06/22 | | |
OPAILEC, NCT06432309: Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease |
|
|
| Completed | N/A | 22 | Europe | Opicapone 50 mg, OPC, Duodopa, Levodopa/carbidopa intestinal gel (LCIG) | University Hospital of Ferrara | Parkinson Disease, Effect of Drug | 12/23 | 04/24 | | |
ACTRN12625001182482: The effect of 12-week Yoga intervention on motor symptoms, fear of falling, and quality of Life in Parkinson's disease with duodopa pump in patients age 50 - 80 years old. |
|
|
| Completed | N/A | 10 | | | Academy of Physical Education in Katowice, Academy of Physical Education in Katowice | balance disorders, tremor in Parkinson Disease, fear of falling, gait impairment | | | | |
NCT02906488: Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease |
|
|
| Completed | N/A | 839 | Japan | | AbbVie | Parkinson's Disease | 07/25 | 07/25 | | |
